{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T17:43:08Z","timestamp":1784569388099,"version":"3.55.0"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012630","name":"Zimmer Biomet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012630","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.bcmd.2020.102520","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T05:55:33Z","timestamp":1605765333000},"page":"102520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Modulation of red blood cell oxygen affinity with a novel allosteric modifier of hemoglobin is additive to the Bohr effect"],"prefix":"10.1016","volume":"87","author":[{"given":"Brooke A.","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea K.","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reed W.","family":"Kamyszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Salvagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Welsby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Welsby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bcmd.2020.102520_bb0005","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF01716196","article-title":"The P50 is reduced in critically ill patients","volume":"17","author":"Myburgh","year":"1991","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.bcmd.2020.102520_bb0010","unstructured":"Fylaktakidou KC, Lehn Jm Fau - Greferath R, Greferath R Fau - Nicolau C, Nicolau C. Inositol tripyrophosphate: a new membrane permeant allosteric effector of haemoglobin. (0960-894X (Print))."},{"key":"10.1016\/j.bcmd.2020.102520_bb0015","unstructured":"Biolo A, Greferath R Fau - Siwik DA, Siwik Da Fau - Qin F, et al. Enhanced exercise capacity in mice with severe heart failure treated with an allosteric effector of hemoglobin, myo-inositol trispyrophosphate. (1091\u20136490 (Electronic))."},{"issue":"2","key":"10.1016\/j.bcmd.2020.102520_bb0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2169\/internalmedicine.56.7349","article-title":"Hemoglobin Kansas as a rare cause of cyanosis: a case report and review of the literature","volume":"56","author":"Nagayama","year":"2017","journal-title":"Internal medicine (Tokyo, Japan)"},{"key":"10.1016\/j.bcmd.2020.102520_bb0025","unstructured":"Luo HY, Irving I Fau - Prior J, Prior J Fau - Lim E, et al. Hemoglobin Titusville, a low oxygen affinity variant hemoglobin, in a family of Northern European background. (0361\u20138609 (Print))."},{"key":"10.1016\/j.bcmd.2020.102520_bb0030","unstructured":"Reissmann Kr Fau - Ruth WE, Ruth We Fau - Nomura T, Nomura T. A human hemoglobin with lowered oxygen affinity and impaired heme-heme interactions. (0021\u20139738 (Print))."},{"key":"10.1016\/j.bcmd.2020.102520_bb0035","unstructured":"Shirasawa T, Izumizaki M Fau - Suzuki Y-i, Suzuki Y Fau - Ishihara A, et al. Oxygen affinity of hemoglobin regulates O2 consumption, metabolism, and physical activity. (0021\u20139258 (Print))."},{"key":"10.1016\/j.bcmd.2020.102520_bb0040","unstructured":"Srinivasan AJ, Kausch K, Inglut C, et al. Estimation of Achievable Oxygen Consumption Following Transfusion With Rejuvenated Red Blood Cells. (1532\u20139488 (Electronic))."},{"key":"10.1016\/j.bcmd.2020.102520_bb0045","unstructured":"Guarnone R, Centenara E Fau - Barosi G, Barosi G. Performance characteristics of Hemox-Analyzer for assessment of the hemoglobin dissociation curve. (0390\u20136078 (Print))."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107997962030557X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107997962030557X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:35:41Z","timestamp":1761050141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107997962030557X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":9,"alternative-id":["S107997962030557X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2020.102520","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of red blood cell oxygen affinity with a novel allosteric modifier of hemoglobin is additive to the Bohr effect","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2020.102520","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102520"}}